163 related articles for article (PubMed ID: 30300709)
21. Salt-kneading: alternative sizing of active pharmaceutical ingredients?
Šimek M; Vyňuchal J; Tomášová L
Pharm Dev Technol; 2016 Dec; 21(8):972-979. PubMed ID: 26365246
[TBL] [Abstract][Full Text] [Related]
22. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
Gaisford S; Dennison M; Tawfik M; Jones MD
Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
[TBL] [Abstract][Full Text] [Related]
23. Compaction of crystallographic forms of pharmaceutical granular lactoses. II. Compacts mechanical properties.
Busignies V; Tchoreloff P; Leclerc B; Hersen C; Keller G; Couarraze G
Eur J Pharm Biopharm; 2004 Nov; 58(3):577-86. PubMed ID: 15451532
[TBL] [Abstract][Full Text] [Related]
24. Introduction of a new scaling approach for particle size reduction in toothed rotor-stator wet mills.
Engstrom J; Wang C; Lai C; Sweeney J
Int J Pharm; 2013 Nov; 456(2):261-8. PubMed ID: 24012859
[TBL] [Abstract][Full Text] [Related]
25. The impact of material attributes and process parameters on the micronisation of lactose monohydrate.
Shariare MH; de Matas M; York P; Shao Q
Int J Pharm; 2011 Apr; 408(1-2):58-66. PubMed ID: 21295125
[TBL] [Abstract][Full Text] [Related]
26. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
27. Effect of milling temperatures on surface area, surface energy and cohesion of pharmaceutical powders.
Shah UV; Wang Z; Olusanmi D; Narang AS; Hussain MA; Tobyn MJ; Heng JYY
Int J Pharm; 2015 Nov; 495(1):234-240. PubMed ID: 26315119
[TBL] [Abstract][Full Text] [Related]
28. Micronization of a soft material: air-jet and micro-ball milling.
Saleem IY; Smyth HD
AAPS PharmSciTech; 2010 Dec; 11(4):1642-9. PubMed ID: 21107775
[TBL] [Abstract][Full Text] [Related]
29. Analysis of powder phenomena inside a Fette 3090 feed frame using in-line NIR spectroscopy.
Mateo-Ortiz D; Colon Y; Romañach RJ; Méndez R
J Pharm Biomed Anal; 2014 Nov; 100():40-49. PubMed ID: 25128874
[TBL] [Abstract][Full Text] [Related]
30. Particle size reduction by a hammer mill I: Effect of output screen size, feed particle size, and mill speed.
Hajratwala BR
J Pharm Sci; 1982 Feb; 71(2):188-90. PubMed ID: 7062242
[TBL] [Abstract][Full Text] [Related]
31. The effect of crystal morphology and mill type on milling induced crystal disorder.
Chikhalia V; Forbes RT; Storey RA; Ticehurst M
Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
[TBL] [Abstract][Full Text] [Related]
32. Determination of the surface energy distributions of different processed lactose.
Thielmann F; Burnett DJ; Heng JY
Drug Dev Ind Pharm; 2007 Nov; 33(11):1240-53. PubMed ID: 18058321
[TBL] [Abstract][Full Text] [Related]
33. Cone milling of compacted flakes: process parameter selection by adopting the minimal fines approach.
Samanta AK; Ng KY; Heng PW
Int J Pharm; 2012 Jan; 422(1-2):17-23. PubMed ID: 22001841
[TBL] [Abstract][Full Text] [Related]
34. Different modes of dynamic image analysis in monitoring of pharmaceutical dry milling process.
Nalluri VR; Schirg P; Gao X; Virdis A; Imanidis G; Kuentz M
Int J Pharm; 2010 May; 391(1-2):107-14. PubMed ID: 20188807
[TBL] [Abstract][Full Text] [Related]
35. Improving the API dissolution rate during pharmaceutical hot-melt extrusion I: Effect of the API particle size, and the co-rotating, twin-screw extruder screw configuration on the API dissolution rate.
Li M; Gogos CG; Ioannidis N
Int J Pharm; 2015 Jan; 478(1):103-112. PubMed ID: 25448572
[TBL] [Abstract][Full Text] [Related]
36. Effect of differential surface anisotropy on performance of two plate shaped crystals of aspirin form I.
Jain T; Sheokand S; Modi SR; Ugale B; Yadav RN; Kumar N; Nagaraja CM; Bansal AK
Eur J Pharm Sci; 2017 Mar; 99():318-327. PubMed ID: 28062260
[TBL] [Abstract][Full Text] [Related]
37. Energy-based analysis of milling alpha-lactose monohydrate.
Chen Y; Ding Y; Papadopoulos DG; Ghadiri M
J Pharm Sci; 2004 Apr; 93(4):886-95. PubMed ID: 14999726
[TBL] [Abstract][Full Text] [Related]
38. Investigation into process-induced de-aggregation of cohesive micronised API particles.
Hoffmann M; Wray PS; Gamble JF; Tobyn M
Int J Pharm; 2015 Sep; 493(1-2):341-6. PubMed ID: 26235919
[TBL] [Abstract][Full Text] [Related]
39. Investigating mixing and segregation using discrete element modelling (DEM) in the Freeman FT4 rheometer.
Yan Z; Wilkinson SK; Stitt EH; Marigo M
Int J Pharm; 2016 Nov; 513(1-2):38-48. PubMed ID: 27596114
[TBL] [Abstract][Full Text] [Related]
40. Application of feedback control and in situ milling to improve particle size and shape in the crystallization of a slow growing needle-like active pharmaceutical ingredient.
Yang Y; Pal K; Koswara A; Sun Q; Zhang Y; Quon J; McKeown R; Goss C; Nagy ZK
Int J Pharm; 2017 Nov; 533(1):49-61. PubMed ID: 28935256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
